Summit Therapeutics Inc vs Warner Music Group Corp — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Warner Music Group Corp trades at $28.2 (market cap $14.64B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Warner Music Group Corp pays a 2.71% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | WMG | |
|---|---|---|
Market Cap | $10.48B | $14.64B |
Sector | Health | Media |
52-Week High | $29.32 | $34.72 |
52-Week Low | $13.05 | $23.65 |
Enterprise Value | $9.90B | $18.84B |
Dividend Yield | — | 2.71% |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →